United States Pharmacopeia
The United States Pharmacopeia (USP), a prominent authority in the pharmaceutical industry, is headquartered in Rockville, Maryland, US. Founded in 1820, USP has played a pivotal role in establishing quality standards for medicines, food ingredients, and dietary supplements. With a commitment to public health, USP develops and disseminates scientifically-based standards that ensure the quality, safety, and efficacy of products. USP's core offerings include the Pharmacopeia and National Formulary, which provide comprehensive monographs and quality standards. These resources are unique in their rigorous scientific validation and global acceptance, making USP a trusted partner for manufacturers and regulators alike. Recognised for its leadership in promoting safe and effective healthcare, USP continues to influence the pharmaceutical landscape, ensuring that patients receive high-quality products worldwide.
DitchCarbon Score
How does United States Pharmacopeia's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
United States Pharmacopeia's score of 23 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
United States Pharmacopeia's reported carbon emissions
The United States Pharmacopeia (USP) currently does not have available carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. As such, USP has not publicly committed to any specific climate action frameworks or targets, such as those set by the Science Based Targets initiative (SBTi). Without emissions data or reduction commitments, it is unclear how USP is addressing climate change within its operations. The organisation may still be evaluating its environmental impact or developing future strategies to align with industry standards for sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
United States Pharmacopeia is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
